XML 156 R130.htm IDEA: XBRL DOCUMENT v3.25.0.1
Parent Company Only Financial Statements - Condensed Statements of Cash Flows (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net Income (Loss) $ 118,815 $ 142,048 $ 71,274
Adjustments to reconcile net income to net cash provided by operating activities:      
Stock-based compensation expense 8,048 7,222 6,059
Net cash provided by operating activities 155,271 166,935 214,634
Cash flows from investing activities:      
Sales (purchases) of non-marketable securities, net (44,900) (106,200)  
Net cash provided by (used in) investing activities 64,659 (404,031) (752,137)
Cash flows from financing activities:      
Issuance of stock under purchase and equity compensation plans (1,515) (1,534) (1,481)
Proceeds from exercise of stock options 3,555 617 1,102
Payment of dividends (42,945) (39,643) (30,447)
Net cash (used in) provided by financing activities (284,408) 230,903 (114,198)
Decrease in cash, cash equivalents and restricted cash(1) (64,478) (6,193) (651,701)
Cash, cash equivalents and restricted cash at beginning of the year(1) 192,326 198,519 850,220
Cash, cash equivalents and restricted cash at end of period(1) 127,848 192,326 198,519
Consolidated | Reportable Legal Entities      
Cash flows from operating activities:      
Net Income (Loss) 118,815 142,048 71,274
Adjustments to reconcile net income to net cash provided by operating activities:      
Equity in undistributed earnings of subsidiaries (55,848) (92,990) (30,260)
Stock-based compensation expense 8,048 7,222 6,059
Amortization 311 310 158
Other (2,599) 15,833 (221)
Net cash provided by operating activities 68,727 72,423 47,010
Cash flows from investing activities:      
Cash paid for acquisitions     (67,128)
Investment in subsidiary (2,000)    
Sales (purchases) of non-marketable securities, net 103 (1,773) (11,471)
Net cash provided by (used in) investing activities (1,897) (1,773) (78,599)
Cash flows from financing activities:      
Issuance of stock under purchase and equity compensation plans (1,515) (1,534) (1,481)
Proceeds from exercise of stock options 3,555 617 1,102
Payment of dividends (42,945) (39,644) (30,447)
Net cash (used in) provided by financing activities (40,905) (40,561) (30,826)
Decrease in cash, cash equivalents and restricted cash(1) 25,925 30,089 (62,415)
Cash, cash equivalents and restricted cash at beginning of the year(1) 79,353 49,264 111,679
Cash, cash equivalents and restricted cash at end of period(1) $ 105,278 $ 79,353 $ 49,264